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B'usy In The Meadow
Professor Vincent Dole confesses to a certain "tendency to
meander," At various times he has explored kidney function,
hypertension, obesity, sweat, the mechanisms of body
energy, and the mathematics of electrophoresis. Nineteen
years ago, after establishing such things as the culpability of
sodium in high blood pressure and the unsuspected role of
free fatty acids in body metabolism, he began inviting heroin
addicts to The Rockefeller University Hospital. The result
was methadone maintenance, Today at 70, still at work in the
laboratory, he and his colleagues are trying to make mice
alcoholic.
Although Dr. Dole jokes about meandering, comparing
himself to "a kid in a big meadow who goes from flower to
insect to tree," his course has not been quite so random or
ingenuous. As his analogy suggests, he was drawn to biology
through a fascination with the interdependencies of living sys-
tems, As a clinical scientist, he has channeled this fascination
into studies that all broadly relate to metabolism-the com-
plex, interacting processes of chemistry and physiology
through which organisms utilize energy and maintain life.
Methadone maintenance as a treatment for heroin addic-
tion is the achievement for which Vincent Dole's name is
known to the public. But if methadone hadn't happened, he
could still, as this profile does, look back on a distinguished
career. He's been pretty busy in the meadow.
Vincent Dole
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Vincent Dole and Marie
Nyswander
Thomas Gentry examines
micro-samples ofblood taken
from mice for analysis ofalco-
hol content.
Dr. Dole came to Rockefeller 42 years ago after medical
training and a residency at Massachusetts General Hospital.
He almost didn't make it. Having decided midway through
medical studies at the University of Wisconsin that he should
switch to the more research-oriented program at Harvard, he
relinquished his place at the first before discovering there was
no opening for him at the second. As a result, he spent the
next year in his father's groves in California, learning to cure
olives instead of people. "I probably would have stayed in the
olive oil business," he says, "if my professor of pathology at
Wisconsin hadn't meantime, without my knowing it, con-
vinced the fellows at Harvard they'd made a mistake."
Mathematics runs a close second to biological research in
Dr. Dole's affections. Before biology beckoned, he had
planned to be a mathematician. In his early years at Rockefel-
ler, he worked out a mathematical theory for determining the
distribution of ionic constituents in electrophoresis, a method
for separating and identifying ionized molecules in solution.
His theory remains the standard model. Marie Nyswander, a
laboratory colleague and his wife of 18 years, recounts finding
him, one recent morning at six, feet up on the coffee table,
eager to explain the topology of knots.
BLOOD, SWEAT, AND FAT
Dr. Dole's first appointment at Rockefeller was in the labora-
tory of the late Donald Van Slyke, whose extensive contribu-
tions to clinical laboratory methods laid the foundations for
many chemical and therapeutic procedures still in use.
"Van Slyke's contributions to the study of chemical pro-
cesses in the body were so fundamental," says Dr. Dole, "that
their roots are all but forgotten. He devised the tools and
techniques he needed as he went along. His apparatus for the
measurement of oxygen and carbon dioxide in solution in
blood and other fluids was so simple and precise that it
quickly became standard equipment for medical scientists.
He introduced the concept of the reabsorption of urea into
the bloodstream, a very good measure of kidney function. My
first job in the lab was to work out some of the mathematics
of reabsorption to make the clinical test more exact."
During World War II the Rockefeller Hospital was desig-
nated a naval research unit. Many of its scientists, Dr. Dole
among them, were commissioned naval officers, and turned
their efforts to the needs of the military. "Van Slyke saw that
one important contribution our group might make would be
to develop a quick, easy procedure that could be used in the
field to measure blood density in shock victims in order to
know how much fluid treatment they needed. We came up
with a method that required only a drop of blood in a bottle
of copper sulfate of known density. It was very ingenious.
The N ew York Blood Center still uses it to determine
whether someone has enough hemoglobin to be a donor."
After the war, with Van Slyke's retirement drawing near,
Dr. Dole once again accepted a post at Massachusetts Gen-
eral. A year later, he relates, Thomas Rivers, then director of
the Rockefeller Hospital, 'asked him to return as head of his
own laboratory-to study whatever he chose with whomever
he chose. "I told Rivers that I would like to work on hyper-
tension. It was a disease for which some interesting treat-
ments were being tried and one that clearly had to do with
metabolism, which tied into my experience with Van Slyke. I
asked Lew Dahl from Mass General to join me. 'Then George
Cotzias, another Mass General colleague, simply 'announced
he was coming, too."
Lewis Dahl left Rockefeller in 1952 to head the hospital at
Brookhaven National Laboratories and went on to become a
leading authority in hypertension. George Cotzias, who died
in 1977, worked for many years at Brookhaven, Memorial
Sloan-Kettering, and New York Hospital. In the Dole lab he
began metabolic studies of amines, body chemicals important
in nerve function. From work on dopamine he developed the
drug L-dopa for the treatment of Parkinson's disease.
In the late 1940s, physicians were beginning to achieve
some success in lowering blood pressure through diet manip-
ulation. One theory favored a low-salt diet, another low-pro-
tein. In trials with patients, Dr. Dole and his associates traced
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In the lab. Gathered around
Dr. Thomas Gentry at the
computer keyboard, left to
right: Gwen Cohen, a summer
helper, Assistant for Research
Robert jacobs, Dr. Dole, Dr.
Sinisa Bogdanovic, a visiting
pharmacologist from the Uni-
versity ofBelgrade, Dr. Ann
Ho, Dr. Michael Rappaport,
and Assistant for Research
Adrienne Chin.
the problem to salt, and specifically to the sodium ion. The
blood pressure of patients on the low-protein, low-salt diet
went down, but it rose again when salt was added, while pro-
tein remained low. The low-protein diet did, however, lower
the weight of those patients in the study who were obese.
This raised questions in Dr. Dole's mind about the prevailing
views on protein requirements, and so the laboratory began
obesity studies. George Corner, in his history of Rockefeller,
wrote: "One hardly knows whether to admire more the per-
sistence of the investigators in carrying out the enormous
number of chemical analyses required by this kind of
research, or the willingness of obese women to live for
months upon diets chosen for their specific content, with
palatability a secondary consideration."
All of the patients lost weight on the protein-restricted
diet, but they regained it after leaving the clinic. During his
studies, Dr. Dole observed that markedly obese people don't
necessarily overeat compared with people of normal weight;
that, in fact, in order to maintain a normal weight after reduc-
tion, they have to live continuously on a calorically subnormal
diet. The results of the subnormal diet are often depression
and serious loss of energy. Why this happens-how metabolic
and behavoral elements influence the development of obe-
sity-remains a knotty problem in clinical research. Subse-
quent work at Rockefeller by Professor Jules Hirsch has
helped explain a good deal about normal and abnormal fat-
cell physiology. Dr. Dole's early observation that protein and
nonprotein foods appear to interact to influence appetite is
now being studied in a number of laboratories interested in
the effects of nutrients on some of the recently discovered
brain chemicals.
The laboratory's hypertension studies also revealed that
sweat gland secretions are altered by low-salt diets. Since lit-
tle was known about sweat formation, Dr. Dole and his group
proceeded, in the Van Slyke tradition, to devise methods for
measuring concentrations of salts, urea, and other substances
in sweat and for locating and counting the sweat glands.
Dr. Dole made an important contribution in the 1950s
when he isolated free fatty acids in blood plasma and
explained their .role in carrying energy to tissues. Because
their concentration in the blood is minute, free fatty acids had
been considered by most researchers to serve little or no
metabolic function. They were found, however, to have an
exceptionally rapid turnover. Despite their low concentra-
tion, they were transporting a major fraction of the body's
energy. Dr. Dole traced their origin to triglyceride molecules
stored in fat cells and showed how they interact with insulin
and carbohydrates, findings that have been important to
understanding the events in arteriosclerosis.
"AN ABSOLUTE VACUUM
OF DESPAIR"
In those years Dr. Dole became interested in a problem that,
at first, appeared to be unrelated to his work. Each day, as he
walked the streets of the city, he witnessed what he has
described as "an epidemic growing all around me, drug addic-
tion." He soon learned that "most people, doctors included,
considered addiction solely a psychological or sociological
problem, a consequence of 'bad behavior,' or 'weak charac-
ter.' Moreover, for decades, doctors who tried to treat addicts
were harassed by government narcotics agents and threatened
with the loss of their licenses."
Bad behavior was not a "useful" answer as far as Dr. Dole
was concerned. "I had become sensitized to that kind of cir-
cular thinking when I worked with obese patients," he says.
"It annoyed me to be told that·fat people wouldn't be fat if
they didn't eat so much. That's not a scientific explanation, it's
a moral judgment. Then one day I was talking with Lewis
Thomas, who at the time was chairman of the New York City
Health Department's committee on narcotics. Apparently the
department had decided that with so many addicts around,
they ought to start thinking what to do. Lew was just going on
sabbatical and suggested I take over the chairmanship, which
I did. I spent a very educational year. By the end of it, I was
persuaded that addiction was an attackable problem. The
Health Research Council offered to allocate funds for
research, so I went to Detlev Bronk, who was then president
of the university, and explained what I wanted to do. I
pointed out to him that we'd be inviting some rather unusual
guests into the Rockefeller gardens, that we would probably
be harassed by the Bureau of Narcotics, and that for those
reasons it was a project no other institution wanted to touch.
He replied simply: 'Then we will tackle the problem.' He
never weakened his support. Looking into the field, the per-
son I discovered with the most knowledge and experience of
treating addicts was Marie Nyswander. I asked her to come to
Rockefeller to help me set up my studies."
Dr. Nyswander's experience dated back to the 1940s
when, fresh from medical school, she joined the service. "I
wanted to fight Hitler," she says, "but instead I was sent to
the federal prison hospital in Lexington, Kentucky, which was
the only hospital in the country then, and for many years
thereafter, where addicts were treated. The only treatment
was detoxification. It wasn't very pleasant. After the war, I did
a residency in psychiatry and went into private practice. I
never wanted to see another addict. But I made the mistake
of writing a paper on addiction for the New EnglandJournal of
Medicine, which made me an 'expert,' and I wound up seeing
and treating thousands of addicts. I tried every approach-
hypnosis, psychoanalysis, change of scene, you name it. My
rich patients I sent to Paris. I worked for several years in a
storefront clinic in East Harlem. I was the 'drug-addict lady.'
It was a marvellous and touching experience. There wasn't
much I could do except to arrange for detoxification, in some
cases over and over again, but they were so grateful that
someone cared."
The criminalization of addicts, of people Dr. Nyswander
came to know as friends and whose struggles to survive she
witnessed daily, frustrated and enraged her. Like Dr. Dole,
she believed that medical treatment and research, not jail,
offered the only hope.
In 1964, with the sympathetic and resourceful cooperation
of Rockefeller's nursing staff, Dr. Dole and Dr. Nyswander
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Adrienne Chin, left, and Ann
Ho in the mouse room. Dr. Ho,
a physiological psychologist,
began work in the Dole lab as
a technician while still in
graduate school and became a
member of the Rockefeller fac-
ulty in 1970. She conducted
early studies of the sleep pat-
terns of narcotics addicts and
methadone patients. Currently
she is analyzing the daily
rhythm ofeating and drinking
of the experimental mice in the
laboratory's alcohol studies.
The animals' cages, like the
one shown in closeup on the
front page, were especially
designed for this research by
Dr. Dole. They can be fitted
with up to three bottles con-
taining water and various
solutions ofalcohol or drugs.
Each lick a mouse takes at a
bottle generates an electrical
signal to a computer. To reach
the bottle, the mouse must rest
a forepaw on a horizontal bar,
which provides a ground for
the electrical connection. This
unique apparatus makes it
possible to record minute-to-
minute measurements offluid
consumption. It is simpler to
maintain than conventionally
wired cages, saving work time
for the lab and disturbance to
the mice.
Page 5
Michael Rappaport filling a
pump. When implanted under
the skin ofa mouse, the pump
w£ll deliver a continuous dos-
age ofa drug. Dr. Rappaport
is testing the effect ofvarious
drugs on the appetite for alco-
hol in the experimental
animals.
began testing the effects of various narcotics, working with
addicts who had volunteered to participate. In the course of
their studies, Dr. Dole devised a urine test that is now rou-
tinely used to verify the presence and level of drugs in the
body.
Opiate drugs such as heroin, morphine, and opium, and a
variety of synthetic compounds, are pharmacologically
grouped as narcotics. Although they quell drug craving inter-
changeably, their chemical structures differ and they are
metabolized differently in the body. Heroin became the
street drug of choice because its action is swift and intense.
But its effect is short-lived: within a few hours drug hunger
returns. Drug addicts develop tolerance, which means that as
their systems adjust to a drug they require higher and higher
doses. Therefore, most heroin users eventually must inject
the drug intravenously.
Methadone is a synthetic narcotic, developed in Germany
during the war as an analgesic to replace morphine. When Dr.
Dole and Dr. Nyswander gave methadone to their patients,
the effect was dramatically different from that of the other
drugs they had tried. "Instead of sitting around irritable and
jumpy waiting for the next fix or nodding in a dream world,"
Dr. Dole recalls, "the men began talking about baseball. One
oral dose, taken in a glass of juice, stabilized them for 24
hours, and when they were on methadone, heroin had no
effect. Their behavior became, for all practical purposes,
normal."
A year after trials began, Dr. Dole and Dr. Nyswander
reported in thejournal of the American Medical Association on
their first group of 22 long-term addicts. They stated: "With
this medication and a comprehensive program of rehabilita-
tion, patients have shown marked improvement; they have
returned to school, obtained jobs, and have become recon-
ciled with their families. Medical and psychometric tests have
disclosed no signs of toxicity except constipation."
"Methadone's stabilizing effect results from its slow elimi-
nation from the body," Dr. Dole explains. "Only about two
percent is in the circulation at any time. The rest is held inac-
tive in body tissues. As the active portion is excreted, the tis-
sues release another small amount into the bloodstream. In
that way the nervous system is not subjected to the sudden
hammerblow rises in concentration typical of heroin."
The theoretical understanding of how methadone works
and other studies that ascertained its medical safety took
years of effort. Among those who contributed to this research
from the beginning was a young physician from Cornell Uni-
versity Medical College, Mary Jeanne Kreek, who now con-
ducts related pharmacological investigations in another
Rockefeller laboratory.
The Methadone Maintenance Treatment Program was
soon moved from its small experimental base at Rockefeller
to Beth Israel Medical Center. There, and in other clinics, the
number of addicts seeking treatment grew exponentially. In
1973 Science, the journal ofThe American Association for the
Advancement of Science, reported that officials were "talking
optimistically for the first time in the history of New York's
heroin epidemic." James V. Delong, former director of the
Drug Abuse Council, a non-profit foundation, wrote a few
years ago: "Before the Methadone Maintenance Treatment
Program was developed, all treatment programs relied on
some variation of detoxification, counseling or group therapy,
and hope. But with all these methods, the results were terri-
ble ... So methadone maintenance did, in fact, puncture an
absolute vacuum of despair.,"
Subsequent events have tempered expectations. The epi-
demic has not been eradicated. Dr. Dole attributes some of
the early failures to ignorance of how methadone works,
which resulted in patients receiving dosages inadequate to
stabilize them. Other failures stemmed from premature or
inappropriate attempts to detoxify patients, a procedure that,
as experience has shown, succeeds with only a very small per-
centage of addicts. Many programs do not offer the social and
backup medical services that Dr. Dole and Dr. N yswander
consider crucial at the beginning of treatment for people
weakened and discouraged by years of illness and a marginal
way of life. Further, it is impossible to estimate how many
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have been discouraged or repelled by negative attitudes about
methadone maintenance. In James Delong's opinion: "The
best programs seem to be those whose administrators take a
matter-of-fact, nonpunitive attitude. The Dole-Nyswander
approach is: 'You have a disease called heroin addiction. We
are going to give you methadone, a medicine for it' ... There is
an immense gulf between this and a program operator who
says: 'You, you weak-willed--, are an addict. If you insist
on methadone we will let you have it, but your desire for it
• just shows how worthless you are.'"
At the introduction of methadone maintenance, Dr. Dole
instituted exhaustive record keeping, later administered by an
independent agency. The records show that, notwithstanding
the problems, there are some 30,000 methadone-stabilized
patients in New York. Many have been under treatment for
15 years or more. Dr. Nyswander tells of the distraught
mother who, on learning her 17-year-old son, a heroin addict
since age 13, was too young to be accepted into the program
as then set up, responded: "Thanks a lot, Dr. Nyswander. If,
four years from now, my son is still alive and he's not in
prison, I'll send him to you." That conversation planted the
seeds for the subsequent growth of the Adolescent Develop-
ment Program, begun by Dr. Nyswander at Rockefeller and
now in its own quarters under the direction of psychiatrist
Robert Millman and pediatrician Elizabeth Khuri of New
York Hospital. The boy who inspired the program has since
finished graduate school.
Close to Dr. Dole's heart is the program for using metha-
done to detoxify prisoners in the city's detention centers.
Designed as a humane alternative to "cold turkey," it was set
up in 1971 with the help of volunteer methadone patients
who worked for months without pay and often around the
clock.
There is no cure for heroin addiction. Methadone mainte-
nance is a treatment, as insulin is a treatment for diabetes.
Two-thirds of the patients who discontinue methadone return
to illegal drugs. The underlying knowledge that might lead to
cures remains incomplete.
FROM THE BOTTLE TO THE BRAIN
There is no methadone for people addicted to alcohol. Noth-
ing has yet been found in the existing pharmacopoeia, and Dr.
Dole believes that a new substance may have to be synthe-
sized. It will have to be tested on animals, but for the tests to
have value the animals must be bona fide alcoholics.
"One of the first questions we've had to ask," Dr. Dole
explains, "is whether our mice are taking alcohol as food or as
a drug; because unlike other drugs alcohol has caloric value as
well as pharmacological effect. It's a subtle question. To begin
to find the answer, we had to establish a regular rhythm of
eating and drinking under carefully controlled conditions.
Our mice are kept in a constant-temperature room where the
light is regulated night and day by computers and there's a
minimum of disturbance. Then we ask: When we introduce a
bottle of alcohol solution and they drink it, is the drinking fit-
ting into the normal pattern of feeding and drinking? So far it
seems to be, whi<;h implies that they're taking alcohol as food.
To explore the implications of alcohol consumption further,
we measure the concentration of alcohol being carried in the
bloodstream and perfusing the brain. That information
should help us determine whether the drinking is governed in
any way by an intention by the mice to maintain a certain
blood alcohol level in order to get a drug effect. To that end
we've worked out microchemical methods. We bridge these
occasional measurements-we don't want to do it too often
because that in itself disturbs the normal behavioral pattern-
with computer calculations about probable blood level. The
computers are invaluable when you have licking data coming
in continuously on 120 channels, generating millions of
numbers. If ultimately we establish alcoholic behavior, how
we established it will provide useful information. Did we do it
by stressing the animals, by poisoning them with specific
chemicals, by neurological lesions, or by some other reprodu-
cible manipulation? The answer may give us some clues about
the way human alcoholism develops." 0
